Ownership history in BARCLAYS PLC · 6 quarters on record
This page tracks every 13F SEC filing in which BARCLAYS PLC reported a position in VERONA PHARMA PLC (VRNA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 1,393,716 | +1,283,105 | +1160.0% | 0.03% | $148.7M | — |
| 2025 Q2 | ADDED | 110,611 | +1,110 | +1.0% | 0.00% | $10.5M | — |
| 2025 Q1 | ADDED | 109,501 | +104,188 | +1961.0% | 0.00% | $7.0M | — |
| 2024 Q4 | ADDED | 5,313 | +4,954 | +1379.9% | 0.00% | $246K | — |
As of 2025 Q3 — sorted by position size